Skip to content
10-Q

Quarterly Report

CANCER CAPITAL CORP.

0001554795-21-000381

← back to feed
Filed
Nov 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 5, 2021 6.15M sh
Current Liabilities Q3 2021 · Sep 30, 2021 $362.97K
Current Liabilities Q3 2021 · Dec 31, 2020 $333.04K
Total Liabilities Q3 2021 · Sep 30, 2021 $362.97K
Total Liabilities Q3 2021 · Dec 31, 2020 $333.04K
Current Assets Q3 2021 · Sep 30, 2021 $1.38K
Current Assets Q3 2021 · Dec 31, 2020 $698
Total Assets Q3 2021 · Sep 30, 2021 $1.38K
Total Assets Q3 2021 · Dec 31, 2020 $698
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$7.52K
Cash And Equivalents Q3 2021 · Sep 30, 2020 $1.9K
Cash And Equivalents Q3 2021 · Dec 31, 2019 $218
Stockholders Equity Q3 2021 · Sep 30, 2020 −$325.27K
Stockholders Equity Q3 2021 · Jun 30, 2020 −$318.2K
Stockholders Equity Q3 2021 · Mar 31, 2020 −$311.19K
Stockholders Equity Q3 2021 · Dec 31, 2019 −$301.59K
Sga Expense Q3 2021 · Sep 30, 2020 $2.71K
Sga Expense Q3 2021 · Sep 30, 2020 $10.82K
Net Income Q3 2021 · Sep 30, 2020 −$7.06K
Net Income Q3 2021 · Sep 30, 2020 −$23.68K
Net Income Q3 2021 · Jun 30, 2020 −$7.01K
Net Income Q3 2021 · Mar 31, 2020 −$9.61K
Operating Income Q3 2021 · Sep 30, 2020 −$2.71K
Operating Income Q3 2021 · Sep 30, 2020 −$10.82K